Britain partners with Oxford firm to assess coronavirus vaccine T cell responses.

Britain has signed supply deals for six different coronavirus vaccine candidates, including those being made by AstraZeneca and Pfizer and BioNTech, seen as among the frontrunners in the race for a vaccine.

ATMPS's blockchain platform the world's first solution for personalized medicines.

ATMPS's Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s system...

Thermo Fisher Scientific Expands Direct-to-Patient Clinical Trials Service Offerings.

A newly expanded Direct-to-Patient service offering supports decentralized clinical trials to minimize clinical trial length and costs while maximizing patient enrollment and participation rates.

Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19.

Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel.

Baxter Supports New Study Showing Blood Purification with Oxiris Filter Set Can Play a Role in the Management of Severely Ill COVID-19 Patients.

Baxter International Inc., a global leader in acute care, recognizes the findings of a prospective, multicenter, observational study on data from...

Sanofi, GSK to support COVAX with 200mn doses of Covid-19 vaccine.

Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution...

Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, confirmed that the Ministry of Health...

Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials.

Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials....

Cipla launches ELIFast (IgG ELISA test) for COVID-19 antibody detection.

Cipla Limited announced the commercialisation of antibody detection kits for COVID-19 in India. In partnership with KARWA Ltd. under the technology...